Eight Roads Mergers and Acquisitions Summary

Private Equity Firm Profile

In the last 3 years, Eight Roads has invested in 54 companies.

Eight Roads’ most common sectors for investment arelife science (25%) and internet software and services (21%) . The Firm’s most common investment types include venture (91%) and growth capital (7%). In total, Eight Roads has invested in 19 US states and 18 different countries. Its largest (disclosed) acquisition occurred in 2017 when it acquired Symbiomix Therapeutics for $150M.

In the last 3 years, Eight Roads has exited 31 companies. The Firm’s most common exit type is ipo (48%). Eight Roads’ largest (disclosed) exit occurred in 2021 when it sold Paidy for $2.5B.

Join Mergr to view Eight Roads’ full profile and discover more small private equity firm investors just like it.

M&A Summary

  • M&A Total Activity395
    • M&A Buy Activity298
    • M&A Sell Activity97
  • Total Sectors Invested 31
  • Total Countries Invested 18
  • M&A Buy/Sell Connections 95

Eight Roads

1 St. Martin’s Le Grand,
London, EC1A 4AS
United Kingdom
+44 20 7074 5400
www.eightroads.com
info@eightroads.com

Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.


Investment Criteria

Sectors of Interest: Digital Media, E-Commerce, Education, Financial Services, Healthcare Services, Information Technology, Internet Software and Services, Life Science, Manufacturing, Media, Medical Products, Real Estate, Software

Target Transaction Types: Growth Capital, Venture

Geographic Preferences: East US, Midwest US, South US, West US, United Kingdom, Western Europe, Eastern Europe, Nordic, Asia/Pacific, Central Asia/India

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size - -
Enterprise Value - -

M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (14.4/yr) # 226 18 29 24 1 - 298
vol $201M $201M
Sell (9.6/yr) # 50 17 25 2 - 4 98
vol $2.8B $150M $6.6B $350M $520M $10.4B
  396

Most Recent M&A

Company Date Value Type
Proximie Ltd. 2024-10-23 - Trade Sale
London, United Kingdom · www.proximie.com
Planck Resolution Ltd. 2024-07-23 - Trade Sale
New York, New York · www.planckdata.com
Invetx, Inc. 2024-07-18 520M USD Trade Sale
Boston, Massachusetts · www.invetx.com
Ujala Cygnus Healthcare Services 2024-04-03 - Secondary Sale
New Delhi, India · www.ujalacygnus.com
Adcentrx Therapeutics, Inc. 2023-04-24 - Venture
San Diego, California · www.adcentrx.com
Alternative Bio, Inc. 2022-12-15 - Venture
Singapore, Singapore
Elucidata 2022-09-27 - Venture
Cambridge, Massachusetts · www.elucidata.io
Qixiangyun (Beijing) Information Technology Co., Ltd. 2022-09-14 - Venture
Beijing, China · www.qixiangyun.com
Jade Bird Display 2022-08-10 - Venture
Shanghai, China · www.jb-display.com
Beijing Damaidi Information Technology Co., Ltd. 2022-07-21 - Venture
Beijing, China · www.processon.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Life Science 35 (17%) 150M (100%) 74 (25%) 150M (75%)
Internet Software and Services 40 (19%) - 60 (20%) -
Software 40 (19%) - 49 (16%) -
Information Technology 27 (13%) - 32 (11%) -
Healthcare Services 12 (6%) - 16 (5%) -
Medical Products 11 (5%) - 15 (5%) -
Education 8 (4%) - 8 (3%) -
E-Commerce 4 (2%) - 7 (2%) -
Financial Services 4 (2%) - 5 (2%) -
Electrical Equipment 3 (1%) - 4 (1%) -
Business Services 2 (1%) - 3 (1%) 51M (25%)
Food 3 (1%) - 3 (1%) -
Automotive 1 (< 1%) - 2 (1%) -
Consumer Products 2 (1%) - 2 (1%) -
Transportation 2 (1%) - 2 (1%) -
Apparel/Textiles 1 (< 1%) - 1 (< 1%) -
Beverages 1 (< 1%) - 1 (< 1%) -
Communications 1 (< 1%) - 1 (< 1%) -
Consumer Services 1 (< 1%) - 1 (< 1%) -
Digital Media 1 (< 1%) - 1 (< 1%) -
Distribution 1 (< 1%) - 1 (< 1%) -
Electronics 1 (< 1%) - 1 (< 1%) -
Engineering 1 (< 1%) - 1 (< 1%) -
Furniture 1 (< 1%) - 1 (< 1%) -
Infrastructure - - 1 (< 1%) -
Insurance 1 (< 1%) - 1 (< 1%) -
Manufacturing 1 (< 1%) - 1 (< 1%) -
Marketing 1 (< 1%) - 1 (< 1%) -
Renewable Energy 1 (< 1%) - 1 (< 1%) -
Retail 1 (< 1%) - 1 (< 1%) -
Semiconductors 1 (< 1%) - 1 (< 1%) -
Total 209 $150M 298 $201M

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 74 (35%) 150M (100%) 124 (42%) 150M (75%)
  California 30 (14%) - 43 (14%) -
  Massachusetts 11 (5%) - 34 (11%) -
  New York 13 (6%) - 16 (5%) -
  Illinois 4 (2%) - 5 (2%) -
  New Jersey 4 (2%) 150M (100%) 4 (1%) 150M (75%)
  Washington 2 (1%) - 3 (1%) -
  Pennsylvania 2 (1%) - 3 (1%) -
  Maryland 1 (< 1%) - 3 (1%) -
  North Carolina 1 (< 1%) - 2 (1%) -
  Minnesota 1 (< 1%) - 2 (1%) -
  Wisconsin 1 (< 1%) - 1 (< 1%) -
  Texas 1 (< 1%) - 1 (< 1%) -
  Florida 1 (< 1%) - 1 (< 1%) -
  Delaware 1 (< 1%) - 1 (< 1%) -
  Colorado 1 (< 1%) - 1 (< 1%) -
  Utah - - 1 (< 1%) -
  Ohio - - 1 (< 1%) -
  Montana - - 1 (< 1%) -
  Connecticut - - 1 (< 1%) -
China 51 (24%) - 65 (22%) -
India 29 (14%) - 38 (13%) -
Japan 18 (9%) - 25 (8%) -
United Kingdom 11 (5%) - 18 (6%) 51M (25%)
France 5 (2%) - 6 (2%) -
Germany 4 (2%) - 4 (1%) -
Singapore 4 (2%) - 4 (1%) -
Canada 3 (1%) - 3 (1%) -
  Ontario 2 (1%) - 2 (1%) -
  Nova Scotia 1 (< 1%) - 1 (< 1%) -
Spain 2 (1%) - 2 (1%) -
Netherlands 2 (1%) - 2 (1%) -
Indonesia 1 (< 1%) - 1 (< 1%) -
Ireland 1 (< 1%) - 1 (< 1%) -
Kenya 1 (< 1%) - 1 (< 1%) -
Lithuania 1 (< 1%) - 1 (< 1%) -
Norway 1 (< 1%) - 1 (< 1%) -
Sweden 1 (< 1%) - 1 (< 1%) -
Switzerland - - 1 (< 1%) -
Total 209 $150M 298 $201M

Acquisitions by Deal Type

Type Current # Value All-time # Value
Venture 193 (92%) - 269 (90%) -
Growth Capital 10 (5%) - 19 (6%) -
Stake Purchase 3 (1%) - 4 (1%) -
Secondary Buyout 1 (< 1%) - 2 (1%) 51M (25%)
Buyout (LBO, MBO, MBI) - - 2 (1%) -
Add-on Acquisition 1 (< 1%) 150M (100%) 1 (< 1%) 150M (75%)
PIPE 1 (< 1%) - 1 (< 1%) -
Total 209 $150M 298 $201M

Exits by Deal Type

Type Total # Value
IPO 47 (48%) -
Trade Sale - Public Company 23 (23%) 5.8B (56%)
Trade Sale 22 (22%) 4.6B (44%)
Secondary Sale 4 (4%) -
Bankruptcy 1 (1%) -
SPAC 1 (1%) -
Total 98 $10.4B

Deal Values

buy # Total
$100M to $1B 1 $150M
< $100M 1 $51M
TOTAL $201M
Largest Symbiomix Therapeutics LLC
$150M (2017-10-11)
sell # Total
> $1B 2 $4.6B
$100M to $1B 13 $5.6B
< $100M 4 $243M
TOTAL $10.4B
Largest Paidy Co., Ltd.
$2.5B (2021-09-07)

M&A Connections

Deals
Acquired from
Investor(s)
1%
2 (1%)
Exited to
Investor(s)
4%
4 (4%)
Strategic(s)
46%
45 (46%)

FAQ

When was Eight Roads founded?

Eight Roads was founded in 1969.

What type of investor is Eight Roads?

Eight Roads is a private equity firm.

Where is Eight Roads headquartered?

Eight Roads is headquartered in London, United Kingdom.

 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.